Gentuity
Private Company
Total funding raised: $30M
Overview
Gentuity is a private, commercial-stage medical technology firm focused on revolutionizing intravascular imaging with its High-Frequency Optical Coherence Tomography (HF-OCT) platform. Its core innovation is the 1.8F Vis-Rx catheter, the smallest of its kind, enabling access to tight lesions without pre-dilation and offering rapid, full-vessel imaging. The company is actively selling its system in the US, Europe, and Japan, and is developing its platform with AI integration to enhance procedural guidance in interventional cardiology.
Technology Platform
High-Frequency Optical Coherence Tomography (HF-OCT) intravascular imaging platform featuring the world's smallest (1.8F) imaging catheter, ultra-fast pullback speed, long imaging length, and in-development AI/machine learning software for image analysis.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Competes against major intravascular imaging companies including Philips (Volcano) and Boston Scientific in IVUS, and Abbott Vascular in OCT. Gentuity's primary differentiation is its significantly smaller catheter size, which targets a specific procedural challenge (tight lesions) not easily addressed by larger competitors.